SCHEMBL2210652

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL2213471	0.85	GCK (0.53)	GCKMEN1MAPTKMT2A
	SCHEMBL2215404	0.84	GCK (0.54)	GCKKDRPDGFRAKDM4E
	SCHEMBL2642911	0.84	GCK (0.75)	GCK
	SCHEMBL2210345	0.83	GCK (0.53)	GCKKDRKDM4E
	SCHEMBL2642970	0.83	GCK (0.50)	GCKKDRPDGFRAKDM4E
	SCHEMBL2213008	0.83	GCK (0.58)	GCK
	SCHEMBL2211408	0.82	GCK (0.57)	GCKMAPT
	SCHEMBL2210683	0.82	GCK (0.55)	GCKKMT2A
	SCHEMBL2211308	0.82	GCK (0.47)	GCKMEN1KMT2A
	SCHEMBL2211357	0.82	GCK (0.55)	GCKMEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.